MXCT vs PARA
MaxCyte Inc (MXCT) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
PARA (PARA) common stock.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
PARA does not have a complete income-statement cache yet.
MXCT currently screens at market cap $124.3M. PARA currently screens at market cap $0.
Not investment advice. Open the MXCT and PARA stock pages for the full models.
Not investment advice.